Cargando…
Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents
Ultrasound imaging is a widely used, readily accessible and safe imaging modality. Molecularly-targeted microbubble- and nanobubble-based contrast agents used in conjunction with ultrasound imaging expand the utility of this modality by specifically targeting and detecting biomarkers associated with...
Autores principales: | Johansen, Mette L., Perera, Reshani, Abenojar, Eric, Wang, Xinning, Vincent, Jason, Exner, Agata A., Brady-Kalnay, Susann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922223/ https://www.ncbi.nlm.nih.gov/pubmed/33671448 http://dx.doi.org/10.3390/ijms22041983 |
Ejemplares similares
-
Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
por: Wang, Yu, et al.
Publicado: (2021) -
Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability in vivo and in vitro
por: Perera, Reshani H., et al.
Publicado: (2022) -
A PTPmu Biomarker is Associated with Increased Survival in Gliomas
por: Johansen, Mette L., et al.
Publicado: (2019) -
Detection of Tumor-Specific PTPmu in Gynecological Cancer and Patient Derived Xenografts
por: Vincent, Jason, et al.
Publicado: (2021) -
The unique second wave phenomenon in contrast enhanced ultrasound imaging with nanobubbles
por: Chen, Chuan, et al.
Publicado: (2022)